New genomic technique aimed at targeting tumor types for specific therapy

Just two days ago, the FDA approved a new genomic technique designed to identify tumor markers for specific therapy.  Because cancers can be rapidly mutating in terms of markers, this test can help identify those key receptors and help streamline treatment.

Full article: http://www.onclive.com/web-exclusives/fda-approves-foundationone-cdx-cms-agrees-to-cover-for-medicare-beneficiaries

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: